Announcing The FEBS Journal Richard Perham Prizewinner 2022

The FEBS Journal awards an annual prize of €5000, split between the first and senior authors, in recognition of an important research paper published by the journal in the preceding year.
Announcing The FEBS Journal Richard Perham Prizewinner 2022
Like

Share this post

Choose a social network to share with, or copy the shortened URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

We are delighted to announce that The FEBS Journal Richard Perham Prize 2022 has been awarded for an outstanding paper published by Eilika Weber-Ban and co-authors (Institute of Molecular Biology & Biophysics, ETH Zurich, Switzerland) in The FEBS Journal in 2021. We invite you to read through their excellent paper below:

Genome-wide interaction screen for Mycobacterium tuberculosis ClpCP protease reveals toxin–antitoxin systems as a major substrate class

By Michal Ziemski, Julia Leodolter, Gabrielle Taylor, Anne Kerschenmeyer, Eilika Weber-Ban

Here is a brief summary of this work:

The ClpCP chaperone–protease complex is essential in mycobacteria, making it an attractive drug target in the treatment of tuberculosis. Eilika Weber-Ban and co-authors adapted a high-throughput bacterial adenylate cyclase two-hybrid screening system to probe the interactome of the ClpCP protease in Mycobacterium tuberculosis to identify interaction partners at the genome-wide level. They identify toxin-antitoxin systems as a major substrate class and also show that the ClpCP protease is involved in the post-translational regulation of type II toxin-antitoxin systems, implicating the pathway in the development of bacterial persistence.

Huge congratulations to Eilika Weber-Ban and colleagues for this exciting work!

Join the FEBS Network today

Joining the FEBS Network’s molecular life sciences community enables you to access special content on the site, present your profile, 'follow' contributors, 'comment' on and 'like' content, post your own content, and set up a tailored email digest for updates.